Table 1 Proposed classification of flat intraurothelial lesions of the bladder.

From: Flat intraurothelial lesions of the urinary bladder—do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice

Koss15 (1975)

Nagy et al.16 (1982)

Mostofi and Sesterhenn17 (1984)

1986 CIS Workshop18

Murphy et al. 20 (1994)

1998 ISUP/WHO5

2004 WHO22

2016 WHO1

2021 GUPS[a25

• Simple hyperplasia

• Atypical hyperplasia

• CIS

• Atypia, NOS

• Mild dysplasia

• Moderate dysplasia

• Severe dysplasia

• CIS

• CIS, grade I

• CIS, grade II

• CIS, grade III

• Slight dysplasia (Intraurothelial neoplasia 1)

• Moderate dysplasia (Intraurothelial neoplasia 2)

• Marked dysplasia/CIS (Intraurothelial neoplasia 3)

• Dysplasia

• CIS

• Hyperplasia

• Reactive atypia

• AUS

• Dysplasia (Low-grade intraurothelial neoplasia)

• CIS (High-grade intraurothelial neoplasia)

• Hyperplasiab (includes papillary and flat)

• Reactive atypiab

• AUSb

• Dysplasiab (Low-grade intraurothelial neoplasia)

• CIS (High-grade intraurothelial neoplasia)

• UPUMP (includes papillary and flat)

• Reactive atypiab

• AUSb

• Dysplasia

• CIS

• AUP-flat

• Dysplasia

• CIS

  1. aOnly for non-inflammatory flat intraurothelial lesions.
  2. bNot listed in WHO tumor classification.